Urocortin 3 activates AMPK and AKT pathways and enhances glucose disposal in rat skeletal muscle

Local overexpression of the myostatin propeptide increases glucose transporter expression and enhances skeletal muscle glucose disposal

(2014) M. E. Cleasby et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Chronic resistance training activates autophagy and reduces apoptosis of muscle cells by modulating IGF-1 and its receptors, Akt/mTOR and Akt/FOXO3a signaling in aged rats

(2013) Li Luo et al.   EXPERIMENTAL GERONTOLOGY

Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart

(2013) J. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Vascular Effects of Urocortins 2 and 3 in Healthy Volunteers

(2013) Sowmya Venkatasubramanian et al.   Journal of the American Heart Association

IGF and myostatin pathways are respectively induced during the earlier and the later stages of skeletal muscle hypertrophy induced by clenbuterol, aβ2-adrenergic agonist

(2012) Tokuhisa Abo et al.   CELL BIOCHEMISTRY AND FUNCTION

Muscle protein anabolism in type 2 diabetes

(2012) Maya S. Bassil et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Overexpression of the Adiponectin Receptor AdipoR1 in Rat Skeletal Muscle Amplifies Local Insulin Sensitivity

(2012) S. A. Patel et al.   ENDOCRINOLOGY

Urocortins Improve Dystrophic Skeletal Muscle Structure and Function through Both PKA- and Epac-Dependent Pathways

(2011) Julie Reutenauer-Patte et al.   AMERICAN JOURNAL OF PATHOLOGY

Urocortin 3 transgenic mice exhibit a metabolically favourable phenotype resisting obesity and hyperglycaemia on a high-fat diet

(2011) P. M. Jamieson et al.   DIABETOLOGIA

Type 2 Corticotropin-Releasing Factor Receptor in the Ventromedial Nucleus of Hypothalamus Is Critical in Regulating Feeding and Lipid Metabolism in White Adipose Tissue

(2011) Hongxia Chao et al.   ENDOCRINOLOGY

Sarcopenia: characteristics, mechanisms and functional significance

(2010) M. V. Narici et al.   BRITISH MEDICAL BULLETIN

FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy

(2010) Bin Zheng et al.   FASEB JOURNAL

Coordinated maintenance of muscle cell size control by AMP-activated protein kinase

(2010) Louise Lantier et al.   FASEB JOURNAL

Perifornical Urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis

(2010) Y. Kuperman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis

(2009) Peilin Chen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes

(2009) R. A. DeFronzo et al.   DIABETES CARE

Mechanisms of action and clinical implications of cardiac urocortin: A journey from the heart to the systemic circulation, with a stopover in the mitochondria

(2009) Erlene Kuizon et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Overexpression of IGF-1 in Muscle Attenuates Disease in a Mouse Model of Spinal and Bulbar Muscular Atrophy

(2009) Isabella Palazzolo et al.   NEURON

Sarcopenic obesity: definition, cause and consequences

(2008) Sari Stenholm et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Mighty is a novel promyogenic factor in skeletal myogenesis

(2008) Amy Marshall et al.   EXPERIMENTAL CELL RESEARCH

Identification of a Novel Pool of Extracellular Pro-myostatin in Skeletal Muscle

(2008) Sarah B. Anderson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY